arrow
P

Paolo Gisondi

university of verona
H指数:65
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Evaluation of multimodal large language models for psoriasis diagnosis, severity grading, and treatment recommendations from clinical photographs: ChatGPT shows superior performance compared to other large language models

基于临床照片的银屑病诊断、严重程度分级和治疗建议的多模态大型语言模型评估:ChatGPT的性能优于其他大型语言模型

2026-11-120
OAAI
Efficacy of Apremilast in Patients with Psoriasis with Limited Skin Involvement, Including High-Impact Site Involvement: A Pooled Analysis of Six Trials

阿普米ast在皮肤受累范围有限且包括重要部位受累的银屑病患者中的疗效:六项试验的合并分析

2026-10-020
OA
Real-world trajectories in psoriatic arthritis under risankizumab therapy

鲁安沙利单抗治疗下银屑病关节炎患者的真实世界轨迹

2026-09-230
PRE
A Real-Life, Multicenter, Retrospective Study on Epidemiological and Clinical Features of Patients With Hidradenitis Suppurativa and Concomitant Down Syndrome

一项关于 Hidradenitis Suppurativa 合并 Down 综合征患者流行病学和临床特征的回顾性、多中心、真实世界研究

2026-09-110
OA
Baricitinib versus ritlecitinib for severe alopecia areata: A 24-week real-world study
2026-09-010
PRE
Bridging psoriasis and metabolic comorbidities: Toward comprehensive patient management. Priorities from the International Psoriasis Council

银屑病与代谢性合并症的联系:迈向全面的病人管理。国际银屑病委员会的优先事项

2026-07-250
OA
Efficacy of Bimekizumab on Palmoplantar Psoriasis: A 16-Week Multicenter Retrospective Study—IL PSO (Italian Landscape PSOriasis)

比mekizumab对掌跖银屑病的疗效:一项16周的多中心回顾性研究—IL PSO(意大利银屑病景观)

2026-05-280
OAAI
Treatment-associated phenotype switching between psoriasis and atopic dermatitis

银屑病和特应性皮炎治疗相关的表型转换

2026-05-140
PRE
Clinical and Mechanistic Evidence for Comano Thermal Water: A Narrative Review

康mano温泉的临床与机制证据:一项叙事性综述

2026-04-280
OAAI